Genetic changes in B-cell chronic lymphocytic leukemia;Anomalies génétiques des leucémies lymphoides chroniques

Pathologie Biologie

Volumn 51, Issue 6, 2003, Pages 366-374

  Leroux, D ^a   Lefebvre, C ^a   Callanan, M ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Chromosomal aberrations; FISH; Prognosis; VH mutations

Indexed keywords

ANTIGEN SPECIFICITY; B CELL LEUKEMIA; CELL PROLIFERATION; CELL TRANSFORMATION; CHROMOSOME 11Q; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME 6Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; CORRELATION ANALYSIS; CYTOGENETICS; DISEASE COURSE; FOLLOW UP; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; LYMPHOMA; MULTIVARIATE ANALYSIS; MYELOMA; PREDICTION; RECURRENT DISEASE; REVIEW; SURVIVAL; SURVIVAL TIME;

EID: 0042360626     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(03)00083-X     Document Type: Article

References (58)

1. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, et al. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994;8:1640-5.
2. Juliusson G, Oscier D, Gahrton G. Cytogenetic findings and survival in B-cell chronic lymphocytic leukemia. Second IWCCLL compilation of data on 662 patients. Leuk Lymphoma 1991(Supplement): 21-5.
3. Juliusson G, Gahrton G. Chromosome aberrations in B-cell chronic lymphocytic leukemia. Pathogenetic and clinical implications. Cancer Genet Cytogenet 1990;45:143-60.
4. Dohner H, Stilgenbauer S, Benner A, Leupolt E, Krober A, Bullinger L, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000;343:1910-6.
5. Bentz M, Huck K, du Manoir S, Joos S, Werner CA, Fischer K, et al. Comparative genomic hybridization in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 1995;85:3610-8.
6. Wolf S, Mertens D, Schaffner C, Korz C, Dohner H, Stilgenbauer S, et al. B-cell neoplasia associated gene with multiple splicing (BCMS): the candidate B-CLL gene on 13q14 comprises more than 560 kb covering all critical regions. Hum Mol Genet 2001;10:1275-85.
7. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002;99:15524-9.
8. Dohner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M, et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997;89:2516-22.
9. Dohner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, et al. p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 1995;85:1580-9.
10. Neilson JR, Auer R, White D, Bienz N, Waters JJ, Whittaker JA, et al. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival. Leukemia 1997;11:1929-32.
11. Cuneo A, Bigoni R, Rigolin GM, Roberti MG, Bardi A, Cavazzini F, et al. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance. Haematologica 2002;87:44-51.
12. Stankovic T, Weber P, Stewart G, Bedenham T, Murray J, Byrd PJ, et al. Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia. Lancet 1999;353:26-9.
13. Schaffner C, Stilgenbauer S, Rappold GA, Dohner H, Lichter P. Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia. Blood 1999;94:748-53.
14. Bullrich F, Rasio D, Kitada S, Starostik P, Kipps T, Keating M, et al. ATM mutations in B-cell chronic lymphocytic leukemia. Cancer Res 1999;59:24-7.
15. Vorechovsky I, Luo L, Ortmann E, Steinmann D, Dork T. Missense mutations at ATM gene and cancer risk. Lancet 1999;353:1276.
16. Boultwood J. Ataxia telangiectasia gene mutations in leukaemia and lymphoma. J Clin Pathol 2001;54:512-6.
17. Einhorn S, Burvall K, Juliusson G, Gahrton G, Meeker T. Molecular analyses of chromosome 12 in chronic lymphocytic leukemia. Leukemia 1989;3:871-4.
18. Gahrton G, Robert KH, Friberg K, Juliusson G, Biberfeld P, Zech L. Cytogenetic mapping of the duplicated segment of chromosome 12 in lymphoproliferative disorders. Nature 1982;297:513-4.
19. Dierlamm J, Wlodarska I, Michaux L, Vermeesch JR, Meeus P, Stul M, et al. FISH identifies different types of duplications with 12q13-15 as the commonly involved segment in B-cell lymphoproliferative malignancies characterized by partial trisomy 12. Genes Chromosomes Cancer 1997;20:155-66.
20. Hernandez JM, Mecucci C, Criel A, Meeus P, Michaux I, Van Hoof A, et al. Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. Leukemia 1995;9:2140-6.
21. Criel A, Wlodarska I, Meeus P, Stul M, Louwagie A, Van Hoof A, et al. Trisomy 12 is uncommon in typical chronic lymphocytic leukaemias. Br J Haematol 1994;87:523-8.
22. Bullinger L, Krautle C, Busch R, Krober A, Emmerich B, Hallek M, et al. Incidence and correlation of genomic aberrations with clinical and biological risk factors in B-CLL stage Binet-A within the CLL1 trial of the GCLLSG. Blood 2001;98 Abstract 1512.
23. Geisler CH, Philip P, Christensen BE, Hou-Jensen K, Pedersen NT, Jensen OM, et al. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients. Leuk Res 1997;21:1011-23.
24. Chevallier P, Penther D, Avet-Loiseau H, Robillard N, Ifrah N, Mahe B, et al. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia. Br J Haematol 2002;116:142-50.
25. Fenaux P, Preudhomme C, Lai JL, Quiquandon I, Jonveaux P, Vanrumbeke M, et al. Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report on 39 cases with cytogenetic analysis. Leukemia 1992;6:246-50.
26. el Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R, et al. p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression. Blood 1993;82:3452-9.
27. Gaidano G, Newcomb EW, Gong JZ, Tassi V, Neri A, Cortelezzi A, et al. Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia. Am J Pathol 1994;144:1312-9.
28. Callet-Bauchu E, Rimokh R, Tigaud I, Pages J, Gazzo S, Bastion Y, et al. dic(4;17)(p11;p11): a new recurrent chromosomal abnormality in chronic B-lymphoid disorders. Genes Chromosomes Cancer 1996;17:185-90.
29. Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002;100:1177-84.
30. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 1990;323:720-4.
31. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999;17:3835-49.
32. Offit K, Louie DC, Parsa NZ, Filippa D, Gangi M, Siebert R, et al. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood 1994;83:2611-8.
33. Stilgenbauer S, Bullinger L, Benner A, Wildenberger K, Bentz M, Dohner K, et al. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia. Leukemia 1999;13:1331-4.
34. Zhang Y, Matthiesen P, Harder S, Siebert R, Castoldi G, Calasanz MJ, et al. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization. Genes Chromosomes Cancer 2000;27:52-8.
35. Finn WG, Kay NE, Kroft SH, Church S, Peterson LC. Secondary abnormalities of chromosome 6q in B-cell chronic lymphocytic leukemia: a sequential study of karyotypic instability in 51 patients. Am J Hematol 1998;59:223-9.
36. Avet-Loiseau H, Li JY, Facon T, Brigaudeau C, Morineau N, Maloisel F, et al. High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res 1998;58:5640-5.
37. Dascalescu C, Gressin R, Callanan M, Sotto JJ, Leroux D. t(11;14) (q13;q32): chronic lymphocytic leukaemia or mantle cell leukaemia? [letter]. Br J Haematol 1996;95:572-3.
38. Jonveaux P, Hillion J, Bennaceur AL, d'Agay MF, Brice P, Daniel MT, et al. t(14;18) and bcl-2 gene rearrangement in a B-chronic lymphocyfic leukaemia. Br J Haematol 1992;81:620-1.
39. Adachi M, Cossman J, Longo D, Croce CM, Tsujimoto Y. Variant translocation of the bcl-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 1989;86:2771-4.
40. Larsen CJ, Mecucci C, Leroux D. t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas. Nouv Rev Fr Hematol 1990;32:401-3.
41. Michaux L, Mecucci C, Stul M, Wlodarska I, Hernandez JM, Meeus P, et al. BCL3 rearrangement and t(14;19)(q32;q13) in lymphoproliferative disorders. Genes Chromosomes Cancer 1996;15:38-47.
42. McKeithan TW, Takimoto GS, Ohno H, Bjorling VS, Morgan R, Hecht BK, et al. BCL3 rearrangements and t(14;19) in chronic lymphocyfic leukemia and other B-cell malignancies: a molecular and cytogenetic study. Genes Chromosomes Cancer 1997;20:64-72.
43. Yoffe G, Howard-Peebles PN, Smith RG, Tucker PW, Buchanan GR. Childhood chronic lymphocytic leukemia with (2;14) translocation. J Pediatr 1990;116:114-7.
44. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, et al. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 2001;98:3413-20.
45. Fell HP, Smith RG, Tucker PW. Molecular analysis of the t(2;14) translocation of childhood chronic lymphocytic leukemia. Science 1986;232:491-4.
46. Richardson AL, Humphries CG, Tucker PW. Molecular cloning and characterization of the t(2;14) translocation associated with childhood chronic lymphocytic leukemia. Oncogene 1992;7:961-70.
47. Kuppers R, Sonoki T, Satterwhite E, Gesk S, Harder L, Oscier DG, et al. Lack of somatic hypermutation of IG V(H) genes in lymphoid malignancies with t(2;14)(p13;q32) translocation involving the BCL11A gene. Leukemia 2002;16:937-9.
48. Beà S, Lopez-Guillermo A, Ribas M, Puig X, Pinyol M, Carrio A, et al. Genetic imbalances in progressed B-cell chronic lymphocytic leukemia and transformed large-cell lymphoma (Richter's syndrome). Am J Pathol 2002;161:957-68.
49. Fais F, Ghiotto F, Hashimoto S, Sellars B, Valetto A, Allen SL, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest 1998;102:1515-25.
50. Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-54.
51. Liu YJ, Banchereau J. Regulation of B-cell commitment to plasma cells or to memory B cells. Semin Immunol 1997;9:235-40.
52. Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-7.
53. Krober A, Seiler T, Benner A, Bullinger L, Bruckle E, Lichter P, et al. V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocyfic leukemia. Blood 2002;100:1410-6,
54. Ghia P, Guida G, Stella S, Gottardi D, Geuna M, Strola G, et al. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic leukemia (CLL) patients at risk of disease progression. Blood 2003 sous-presse.
55. Lin K, Sherrington PD, Dennis M, Matrai Z, Cawley JC, Pettitt AR. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood 2002;100:1404-9.
56. Rosenwald A, Alizadeh AA, Widhopf G, Simon R, Davis RE, Yu X, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med 2001;194:1639-47.
57. Klein U, Tu Y, Stolovitzky GA, Mattioli M, Cattoretti G, Husson H, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001;194:1625-38.
58. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000;403:503-11.